Quarterly Result19 Jun 2026, 04:40 pm
Crestchem approves Q4/FY26 results, recommends ₹1.50 dividend, forms subsidiary
AI Summary
Crestchem Ltd's Board of Directors approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26, subject to shareholder approval at the upcoming 34th Annual General Meeting. Additionally, the company announced the formation of a new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, incorporated on March 31, 2026, and approved an investment of up to ₹2.25 Crores in it. The board also approved the reappointments and remunerations of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms.
Key Highlights
- Board approved Audited Standalone & Consolidated Financial Results for Q4/FY26.
- Recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26.
- Formed a new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, on March 31, 2026.
- Approved investment up to ₹2.25 Crores in the new subsidiary.
- Reappointed three directors for five-year terms with approved remuneration.
Price Impact
More from CRSTCHM